Olmesartan Medoxomil Krka

Olmesartan medoxil, the active ingredient in Olmesartan Medoxomil Krka, is an Angiotensin II receptor blocker (ARB) presented as a tablet for oral use. It is used to manage high blood pressure in adult patients. GNH USA supplies Olmesartan Medoxomil Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Olmesartan Medoxomil Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Olmesartan medoxil is an ARB that lowers blood pressure by blocking the renin‑angiotensin system.

- Hypertension: helps lower systolic and diastolic blood pressure in adults. - Heart failure: used as part of combination therapy to improve cardiac output and reduce hospitalisation risk. - Diabetic nephropathy: slows progression of kidney damage associated with type 2 diabetes.

Olmesartan medoxil may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Dizziness - Headache - Fatigue - Nasal congestion - Diarrhoea - Cough

Serious or Rare Side Effects: - Angio‑angry  - Hyper‑hyper  - Hepatitis  - Severe hypotension - Acute kidney injury - Elevated potassium - Liver enzyme elevation

Olmesartan medoxil should be used with caution in several 

- Renal impairment: monitor  -  - \n-  ewline -  ewline   -  - lank  ewline   ewline   ewline  ewline  ewline -  ewline  ewline ",